Table 1 Relationship between RelB expression and clinico-pathological characteristics
From: RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells
Characteristics | Total N = 93 | RelB expression | p value | |
|---|---|---|---|---|
High N = 53 | Low N = 40 | |||
Age (years) | ||||
 ≤ 60 | 34 | 18 | 16 | 0.549 |
 > 60 | 59 | 35 | 24 | |
Gender | ||||
 Male | 52 | 28 | 24 | 0.491 |
 Female | 41 | 25 | 16 | |
Site | ||||
 Right | 34 | 19 | 15 | 0.915 |
 Left | 53 | 29 | 24 | |
 Unknown | 6 | 5 | 1 |  |
Differentiation | ||||
 Well | 2 | 1 | 1 | 0.332 |
 Moderate | 73 | 39 | 34 | |
 Poor | 18 | 13 | 5 | |
Depth of tumor invasion | ||||
 T1 | 0 | 0 | 0 | 0.018* |
 T2 | 5 | 1 | 4 | |
 T3 | 64 | 32 | 32 | |
 T4 | 16 | 13 | 3 | |
 Unknown | 8 | 1 | 7 | |
Lymph nodes | ||||
 N0 | 51 | 21 | 30 | < 0.001*** |
 N1 | 28 | 22 | 6 | |
 N2 | 9 | 9 | 0 | |
 Unknown | 5 | 1 | 4 | |
Metastasis | ||||
 Yes | 4 | 4 | 0 | 0.031* |
 No | 89 | 49 | 40 | |
pTNM stage | ||||
 I | 4 | 1 | 3 | 0.001*** |
 II | 41 | 14 | 27 | |
 III | 35 | 29 | 6 | |
 IV | 4 | 4 | 0 | |
 Unknown | 9 | 5 | 4 | |